What is Diclofenac Potassium and Paracetamol tablets used for?

In the pharmaceutical industry, the combination of Diclofenac Potassium and Paracetamol is a potent Fixed-Dose Combination (FDC) categorized as a dual-action analgesic and anti-inflammatory.

As a pharmacist and manufacturer, I view this as a “fast-acting” synergy. While Paracetamol is a standard pain reliever, the addition of the Potassium salt of Diclofenac (rather than the Sodium salt) ensures quicker absorption, making this combination ideal for acute conditions where rapid relief is the priority.

Primary Clinical Uses

  • Acute Musculoskeletal Pain: Effective for backaches, sprains, strains, and sports injuries.

  • Post-Operative & Dental Pain: Widely prescribed after minor surgeries or tooth extractions to manage both trauma-induced pain and swelling.

  • Inflammatory Conditions: Symptomatic relief for Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis.

  • Gynecological Pain: Highly effective for severe dysmenorrhea (period cramps) due to its ability to inhibit prostaglandins in the uterine tissue.

Mechanism of Action: The Synergistic Attack

1. Diclofenac Potassium (50 mg)

  • Action: A non-selective COX-1 and COX-2 inhibitor.

  • Result: It reduces the production of prostaglandins at the site of injury. Because it is the Potassium salt, it dissolves more rapidly in the stomach than Diclofenac Sodium, leading to a faster onset of action (typically within 15–30 minutes).

2. Paracetamol (325 mg – 500 mg)

  • Action: Primarily acts on the Central Nervous System (CNS).

  • Result: It raises the overall pain threshold and acts as an antipyretic to reduce fever. When paired with Diclofenac, it provides a “central” block to pain while the Diclofenac provides a “peripheral” block at the site of inflammation.

The Manufacturer’s Perspective: Technical & Export

From a production standpoint at your WHO-GMP facility in Mumbai, this formulation offers significant B2B advantages:

  • The “Potassium” USP: On your digital platforms, you should highlight that your formulation uses Diclofenac Potassium. For B2B buyers, this is a “Premium” version of the drug compared to the slower-acting Sodium version, justifying a better market position.

  • Gastric Protection: Diclofenac can be hard on the stomach. At our facility, we often utilize Film-Coating technology to protect the gastric mucosa and mask the bitter taste of the APIs, which improves patient compliance.

  • Stability & Packaging: Both APIs are sensitive to moisture. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life, which is critical for your export business to Zone IVb regions.

  • Dossier Support: Our Mumbai-based firm provides full CTD/eCTD Dossiers to support international registration and supply against global brands like Voveran Plus.

 

What is diclofenac potassium and Paracetamol tablets used for?

In the pharmaceutical industry, the combination of Diclofenac Potassium (50 mg) and Paracetamol (325 mg or 500 mg) is a powerhouse Fixed-Dose Combination (FDC). As a pharmacist, you recognize this as a “dual-pathway” analgesic strategy that provides superior relief compared to using either agent alone, making it a staple for acute and chronic pain management.

Primary Clinical Uses

  • Musculoskeletal Pain: Highly effective for backaches, sprains, strains, and sports-related injuries where both pain and localized swelling are present.

  • Arthritic Conditions: Used to manage acute flares of Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis by reducing joint stiffness and inflammation.

  • Post-Operative & Post-Traumatic Pain: Frequently prescribed after surgeries or dental procedures (like tooth extractions) to manage inflammation-driven pain.

  • Acute Dental & ENT Pain: Targeted relief for severe toothaches, earaches, and throat pain.

  • Gynae-related Pain: Effective for primary dysmenorrhea (painful menstrual cramps) due to its potent anti-prostaglandin activity.

Mechanism of Action: The Synergistic Advantage

This combination addresses pain from two different physiological directions:

Diclofenac Potassium (Peripheral Action): It is a potent NSAID that inhibits COX-1 and COX-2 enzymes. By blocking the synthesis of prostaglandins at the site of injury, it directly reduces inflammation, swelling, and localized pain. The “Potassium” salt is chosen for its rapid dissolution, ensuring a faster onset of action than the sodium version.

Paracetamol (Central Action): It primarily acts on the Central Nervous System (CNS) to increase the overall pain threshold. It also serves as an antipyretic (fever reducer). While it has minimal anti-inflammatory effect, it complements Diclofenac by providing a second layer of pain relief.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing standpoint, this FDC is a high-volume product requiring precise pharmaceutical engineering:

  • Bilayer Tablet Formulation: As a WHO-GMP manufacturer, we often utilize bilayer technology to separate the two active ingredients. This can be used to create a “Fast-Release” Paracetamol layer and a “Sustained-Release” Diclofenac layer, ensuring immediate relief with prolonged anti-inflammatory coverage.

  • Excipient Synergy: We focus on the selection of super-disintegrants to ensure that the Diclofenac Potassium reaches peak plasma concentration ($T_{max}$) as quickly as possible, justifying the “fast-acting” label.

  • Packaging for Stability: Due to the hygroscopic nature of Paracetamol and the light sensitivity of Diclofenac, we utilize Alu-Alu blister packaging or high-grade PVC/PVDC. This ensures a 36-month shelf life for export to hot and humid Zone IVb climates.

  • Dossier Support: Our Mumbai facility provides comprehensive CTD/eCTD Dossiers and comparative dissolution studies (IP/BP/USP) to help international B2B partners register the product in African, Southeast Asian, and Middle Eastern markets.

 

Add to cart